High Court at Calcutta, Civil Appellate Jurisdiction, Original Side, Division Bench | Date of Decision: 18th September, 2026 (Reserved on: 22.07.2026) Case Number: TEMPAPO-IPD NO. 6 OF 2025 with IA NO: GA-COM 2 OF 2026; and OCOT NO. 7 OF 2025 Bench: Hon’ble Mr. Justice Sabyasachi Bhattacharyya (author) and Hon’ble Mr. Justice Supratim Bhattacharya Citation:
High Court of Delhi at New Delhi, Single Judge | Date of Decision: 31st August, 2026 Case Number: C.A.(COMM.IPD-PAT) 7/2025 (CNR No. DLHC010119472025) Bench: Hon’ble Ms. Justice Jyoti Singh BACKGROUND The Appellant, Fresenius Kabi iPSUM S.r.l., filed Indian Patent Application No. 201611009993 on 22.03.2016 for an invention titled “AN IMPROVED PROCESS FOR THE PREPARATION OF
Fresenius Kabi Ipsum S.r.l. v. The Asst. Controller of Patents and Designs & Anr. Read More »
High Court of Delhi at New Delhi | Decided: 10 September 2026 CS(COMM) No. 904 of 2026 Bench: Hon’ble Mr. Justice A.J. Bhambhani Background Hindustan Unilever Limited, the plaintiff, is a well-known consumer goods company and the proprietor of the registered trade marks VIM and SURF EXCEL in respect of dishwash and laundry detergent products
Hindustan Unilever Limited v. Kwick Living (I) Private Limited Read More »
High Court of Delhi at New Delhi, Single Judge | Date of Decision: 23.07.2026 (Reserved on: 18.05.2026) Case Number: C.A.(COMM.IPD-PAT) 37/2023 Bench: Hon’ble Mr. Justice Tushar Rao Gedela BACKGROUND The Appellant, Array BioPharma Inc., filed Indian Patent Application No. 450/DELNP/2015 titled “PHARMACEUTICAL COMBINATION COMPRISING A B RAF INHIBITOR AN EGFR INHIBITOR AND OPTIONALLY A PI3K
Array BioPharma Inc. v. Deputy Controller of Patents and Designs Read More »
High Court of Delhi at New Delhi, Single Judge | Date of Decision: 31.08.2026 Case Number: C.A.(COMM.IPD-PAT) 30/2024 & I.A. 11051/2024 (CNR No. DLHC010282532024) Bench: Hon’ble Ms. Justice Jyoti Singh BACKGROUND The Appellant, Cassiopea S.P.A., is an Italian pharmaceutical company engaged in manufacturing, marketing and selling novel pharmaceutical drugs for skin treatment, including for alopecia
Cassiopea S.P.A v. Controller General of Patents and Designs & Ors. Read More »
Copyright in architectural works occupies a distinctive and doctrinally unusual position within Indian intellectual property law a position shaped as much by the physical permanence of buildings and their entanglement with property rights, urban development and public function, as by the ordinary principles of authorial protection that govern paintings, sculptures and literary works. A building
Copyright in Architectural works under Indian law Read More »
The Madrid Protocol represents the single most significant reform to India’s international trademark posture since the enactment of the Trade Marks Act, 1999 itself. For an Indian applicant seeking to protect a brand across multiple jurisdictions, the pre-Madrid alternative was a country-by-country filing exercise involving separate national applications, separate local agents, separate fee structures and
The Madrid protocol – International trademark registration for Indian application Read More »
High Court of Delhi at New Delhi, Division Bench | Date of Decision: January 6, 2026 Case Number: RFA(OS)(COMM) 1/2026 & CM APPL. 331/2026 Bench: Hon’ble Mr. Justice C. Hari Shankar (author) and Hon’ble Mr. Justice Om Prakash Shukla BACKGROUND This appeal challenges, to a limited extent, judgment dated 19 November 2025 and order dated
Mr. Abhimanyu Prakash & Ors. v. Ferrero S.P.A & Ors. Read More »
High Court of Delhi at New Delhi, Single Judge | Date of Decision: April 30, 2026 Case Number: CS(COMM) 1134/2024 Bench: Hon’ble Mr. Justice Tejas Karia BACKGROUND The Plaintiff, Médecins Sans Frontières International (“MSF”/”Doctors Without Borders”), is an international humanitarian medical aid organization operating under the mark ‘Médecins Sans Frontières’/’Doctors Without Borders’ (“Plaintiff’s Mark”) in
Medecins Sans Frontieres International v. Dharma Productions Private Limited and Ors. Read More »
Mergers and acquisitions have always been exercises in identifying, pricing and managing risk. For much of corporate history, that risk was understood primarily in financial, operational and regulatory terms balance sheet liabilities, workforce integration, antitrust clearance and market concentration. In the contemporary deal landscape and most acutely in India’s rapidly maturing M&A market, this understanding
Patent Valuation and Due Diligence in M&A Transactions Read More »